NCT06460012

Brief Summary

STELLA-R is a multicomponent, self-directed, online intervention designed to facilitate effective management of behavioral and psychological symptoms that are common in many types of dementia. The curriculum instructs care partners to use the ABC approach, a cognitive behavioral technique that teaches care partners to describe a Behavior, then consider the Activators and Consequences of a care recipient behavior. The goal of this intervention is to reduce care partner burden and decrease reactivity to upsetting behaviors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
238

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Jul 2024Dec 2026

First Submitted

Initial submission to the registry

June 4, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 14, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

July 2, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

October 23, 2025

Status Verified

October 1, 2025

Enrollment Period

2.4 years

First QC Date

June 4, 2024

Last Update Submit

October 21, 2025

Conditions

Keywords

caregiversdementiaRMBPCcaregiver support

Outcome Measures

Primary Outcomes (3)

  • Revised Memory and Behavior Problems Checklist (RMBPC)

    The primary outcome variable, reactivity, will be assessed with the RMBPC, which measures the frequency of care recipient behavioral symptoms and care partner reactions to these behaviors. The RMBPC was chosen because it aligns with our theoretical foundation that assumes burden is a result of care partner reactions to behavioral symptoms. The RMBPC is a 29-item caregiver report measure, 5-point Likert scale with frequency measuring from 0 (never occurred) to 4 (daily or more often) and reactivity measuring from 0 (not at all) to 4 (extremely) for a total score between 0-116 for each subscale (frequency subscale and reactivity subscale). Higher scores indicate greater behavioral problems.

    Week 1, Week 8, Week 16, Week 24

  • Feasibility of STELLA-R Intervention

    We will assess the feasibility of implementing STELLA-R across Oregon, Washington and Idaho. We will analyze metadata from the STELLA-R website to assess care partner usage of intervention materials. We will assess data from the surveys to characterize the sample, assess program acceptability, and measure treatment fidelity. We will compare demographic information, computer use, health-care usage, behavioral symptom frequency, medication use, care partner reactivity, burden and depression.

    10 months

  • Acceptability of STELLA-R Intervention

    For acceptability, we will utilize the STELLA-R Experience Survey which is a 16-item survey on satisfaction, privacy, and ease of use. We will analyze the STELLA-R Experience Survey results using descriptive statistics. We will identify themes of acceptance, or lack thereof, of STELLA-R and the underpinnings of their impressions.

    Week 24

Secondary Outcomes (13)

  • Fortinsky's Measurement of Family Care Partner Self-Efficacy for Managing Dementia

    Week 1, Week 8, Week 16, Week 24

  • Preparedness for Caregiving Scale

    Week 1, Week 8, Week 16, Week 24

  • Ten-Item Personality Inventory (TIPI)

    Week 1

  • Personalized Target Behavior Survey

    Week 1, Week 8

  • Emotional and Physical Strain

    Weekly for 6 months

  • +8 more secondary outcomes

Study Arms (2)

Experimental Group

EXPERIMENTAL

Care partners start the STELLA-R Curriculum immediately after enrollment.

Behavioral: STELLA-R CurriculumBehavioral: Unrestricted AccessBehavioral: Limited Access

Waitlist Control Group

ACTIVE COMPARATOR

Care partners start the STELLA-R Curriculum 8 weeks after enrollment.

Behavioral: STELLA-R CurriculumBehavioral: Unrestricted AccessBehavioral: Limited Access

Interventions

The STELLA-R curriculum is presented utilizing the ABC analytic approach to address care recipient's distressing behaviors. Using the scaffold of the ABC pyramid, they will receive video instructions on how to fully define the Behaviors they want to address by observing, describing, and writing about them. The care partners will learn to identify the Activators, the triggers for the behaviors. Next, care partners will learn to consider what happens after the behaviors, the Consequences. This is an 8-week self-directed, online weekly curriculum.

Experimental GroupWaitlist Control Group

Following the STELLA-R curriculum, care partners will receive 8 weeks of unrestricted access to all lessons and resources.

Also known as: Post-Intervention Phase, Review Phase
Experimental GroupWaitlist Control Group
Limited AccessBEHAVIORAL

Experimental and Waitlist Control group will experience 8 consecutive weeks of limited access to the STELLA-R website and resources. Waitlist Control will experience this from Week 1 to Week 8 while the Experimental Group will reach this phase from Week 17 to Week 24.

Also known as: Restricted Access
Experimental GroupWaitlist Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult caring for family member with ADRD
  • Age of 18 years or older
  • Speaks and understands English to be able to participate in intervention
  • Owns a telephone (smartphone, cell phone or landline)
  • Has email and mailing address to receive study materials and surveys
  • Provides informed consent to participate in the research
  • Lives in Oregon, Washington or Idaho
  • Identifies two or more behavioral symptoms that are distressing to them (care partner)

You may not qualify if:

  • Vision problems severe enough to prevent participation
  • Unwilling or unable to adequately follow study instructions and participate in study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oregon Health & Science University, Layton Aging and Alzheimer's Disease Research Center

Portland, Oregon, 97239, United States

RECRUITING

MeSH Terms

Conditions

Caregiver BurdenDementia

Condition Hierarchy (Ancestors)

Stress, PsychologicalBehavioral SymptomsBehaviorBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Allison Lindauer, PhD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Allison Lindauer, PhD

CONTACT

Christina Zonker, BA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Care partners will be randomized into one of two groups. Care partners will be blinded to which group they are in.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Care partners will participate in a self-directed, 8-week online course via the STELLA-R website, followed by 8-weeks of unrestricted access to the website, with 8 weeks of restricted access. One group will receive the 8-week online course followed by the 8-week unrestricted access immediately after enrolling. The other group will receive the 8-week online course and 8-week unrestricted access 2 months after enrolling.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 4, 2024

First Posted

June 14, 2024

Study Start

July 2, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

October 23, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

De-identified IPD will be available upon request to our Alzheimer's Disease Research Center.

Shared Documents
STUDY PROTOCOL
Time Frame
Once data is available, it will be available indefinitely.
Access Criteria
Requests need to be made to the PI at the Oregon Alzheimer's Disease Research Center (OARDC). A short data request form will need to be submitted.

Locations